This report was recently updated on May 13 2024 with the latest and most recent
market numbers
Global PCR & Real-time PCR Molecular Diagnostics Market Size, Trends & Analysis - Forecasts to 2029 By Technology (Traditional PCR, Real-time PCR, and Digital PCR), By Application (Infectious Disease Testing, Oncology Testing, Genetic Testing, and Others), By End User (Hospitals, Diagnostic Laboratories, Academic & Research Centers, and Others), and By Region (North America, Asia Pacific, Central and South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis
The global polymerase chain reaction (PCR) & real-time PCR molecular diagnostics market is estimated to exhibit a CAGR of 4.3% from 2024 to 2029.
The primary factors propelling the market growth are the increasing number of PCR molecular diagnostics product launches and the rising prevalence of infectious diseases. Each new product launch often incorporates advancements in PCR technology, such as improved sensitivity, specificity, multiplexing capabilities, and automation. These technological advancements enhance the performance and versatility of PCR testing, driving adoption across various applications and industries. Moreover, companies can reduce product development cycles and launch new PCR molecular diagnostics solutions more quickly due to developments in technology and methodology. Due to their agility, manufacturers can react swiftly to changing consumer demands and industry trends, spurring market expansion with well-timed innovation. For instance, Cepheid announced the launch of its GeneXpert Omni platform in February 2023. This new molecular diagnostics platform is intended to deliver quick and precise results for various infectious diseases.
The market is driven by the growing use of next-generation sequencing (NGS) and the rapid progress of nucleic acid amplification technologies. The polymerase chain reaction often accompanies adopting NGS technologies assays for target amplification before sequencing. PCR-based pre-sequencing workflows enhance NGS's sensitivity, specificity, and efficiency by selectively amplifying genomic regions of interest. This synergistic relationship between NGS and PCR assays drives demand for PCR-based diagnostic solutions compatible with NGS workflows. Additionally, the integration of NGS and PCR-based diagnostic solutions expands the capabilities of molecular diagnostic testing services.
Growing demand for point-of-care testing (POCT) and government initiatives to control infectious diseases propel market growth. The increasing demand for POCT drives the development of PCR detection kits and PCR assay development services tailored for use at the point of care. With PCR-based molecular diagnostics, infectious infections, genetic disorders, and other medical issues can be quickly and accurately detected at the patient's side or in community healthcare settings. This demand for rapid diagnostics fuels the growth of the PCR and real-time PCR molecular diagnostics market.
PCR and real-time PCR molecular diagnostics offer opportunities to identify and validate oncology biomarkers, facilitating early cancer detection, prognosis assessment, and targeted therapy selection. Moreover, the market presents opportunities for the development of companion diagnostics alongside therapeutic drugs, utilizing PCR technologies to identify patients who are most likely to benefit from specific treatments, thereby improving therapeutic outcomes and reducing healthcare costs.
However, stringent regulatory requirements and the high initial setup costs related to PCR molecular diagnostics hinder market growth.
The digital PCR segment is expected to hold the largest share of the market over the forecast period. In order to minimize variability and ensure consistent performance, digital PCR provides absolute standardization of test settings across various laboratories and instruments. This is crucial for harmonizing and comparably interpreting diagnostic data in multicenter research or clinical trials.
The real-time PCR segment is expected to be the fastest-growing segment in the market from 2024 to 2029. Sophisticated real-time PCR instrumentation facilitates multiplexing by allowing the simultaneous detection and quantification of many targets in a single reaction, offering flexibility and diversity for complex diagnostic procedures.
The infectious disease testing segment is expected to hold the largest share of the market over the forecast period. With disorders including HIV/AIDS, hepatitis, tuberculosis, and respiratory infections affecting millions of people globally, infectious diseases provide serious challenges to global health. The need for testing solutions is driven by the speedy and accurate pathogen identification provided by PCR and real-time PCR molecular diagnostics.
The genetic testing segment is anticipated to be the fastest-growing segment in the market from 2024 to 2029. Genomics is experiencing rapid advancements, driven by technological innovations and decreasing costs of DNA sequencing. Genetic testing using PCR enables targeted analysis of specific genetic variants, gene expression patterns, and disease-associated mutations, contributing to the growth of personalized medicine and precision healthcare.
The hospitals segment is expected to hold the largest share of the market over the forecast period. Hospitals are centralized healthcare facilities offering various medical services, such as patient care, treatment, and diagnostic testing. As primary hubs for healthcare delivery, hospitals have the infrastructure, expertise, and resources to perform PCR and real-time PCR molecular diagnostics efficiently and effectively.
The academic & research centers segment is anticipated to be the fastest-growing segment in the market from 2024 to 2029. Academic and research centers frequently collaborate on several projects with healthcare providers, pharmaceutical corporations, and biotechnology firms. These collaborations fuel the need for molecular diagnostics tools as scientists work to understand illnesses better, create novel treatments, and enhance patient outcomes.
North America is expected to be the largest region in the global market. The rising prevalence of infectious diseases, including respiratory infections and sexually transmitted diseases, is fueling the demand for PCR-based diagnostic tests in the North American region. PCR and real-time PCR are vital tools for detecting and monitoring infectious agents with high sensitivity and specificity.
Asia Pacific is anticipated to witness rapid growth during the forecast period. Asia Pacific governments are paying more attention to enhancing patient access to and results from healthcare, including early identification, treatment, and disease prevention. Funding and regulatory frameworks are used to facilitate the deployment of molecular diagnostic technology in public health campaigns and government initiatives.
Abbott Laboratories, Bio-Rad Laboratories, Inc., bioMérieux SA, Danaher Corporation, Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd, QIAGEN N.V., Hologic, Inc., and GRIFOLS, among others, are some of the key players in the global PCR & real-time PCR molecular diagnostics market.
Please note: This is not an exhaustive list of companies profiled in the report.
In April 2023, Qiagen introduced a new family of molecular diagnostics platforms called QIAseq Dx Series. These platforms are intended to deliver accurate and high-throughput findings for several applications.
In March 2023, Roche launched the cobas Liat HPV test, a novel molecular test intended to identify HPV (human papillomavirus) infections.
1 STRATEGIC INSIGHTS ON NEW REVENUE POCKETS
1.1 Strategic Opportunity & Attractiveness Analysis
1.1.1 Hot Revenue Pockets
1.1.2 Market Attractiveness Score
1.1.3 Revenue Impacting Opportunity
1.1.4 High Growing Region/Country
1.1.5 Competitor Analysis
1.1.6 Consumer Analysis
1.2 Global Market Estimates' View
1.3 Strategic Insights across Business Functions
1.3.1 For Chief Executive Officers
1.3.2 For Chief Marketing Officers
1.3.3 For Chief Strategy Officers
1.4 Evaluate the Potential of your Existing Business Lines vs. New Lines to Enter Into
2 TECHNOLOGICAL TRENDS
2.1 Technological Adoption Rate
2.2 Current Trend Impact Analysis
2.3 Future Trend Impact Analysis
3 GLOBAL PCR & REAL-TIME PCR MOLECULAR DIAGNOSTICS MARKET OUTLOOK
3.1 Market Pyramid Analysis
3.1.1 Introduction
3.1.2 Adjacent Market Opportunities
3.1.3 Ancillary Market Opportunities
3.2 Demand Side Analysis
3.2.1 Market Drivers: Impact Analysis
3.2.2 Market Restraints: Impact Analysis
3.2.3 Market Opportunities: Impact Analysis
3.2.4 Market Challenges: Impact Analysis
3.3 Supply Side Analysis
3.3.1 Porter’s Five Forces Analysis
3.3.1.1 Threat of New Entrants
3.3.1.2 Threat of New Substitutes
3.3.1.3 Bargaining Power of Suppliers
3.3.1.4 Bargaining Power of Buyers
3.3.1.5 Intensity of Competitive Rivalry
3.3.2 SWOT Analysis; By Factor (Political & Legal, Economic, and Technological)
3.3.2.1 Political Landscape
3.3.2.2 Economic Landscape
3.3.2.3 Social Landscape
3.3.2.4 Technology Landscape
3.3.3 Value Chain Analysis
3.3.4 Trend Analysis
3.3.5 Gap Analysis
3.3.6 Cost Analysis
4 GLOBAL PCR & REAL-TIME PCR MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY
4.1 Introduction
4.2 PCR & Real-time PCR Molecular Diagnostics Market: Technology Scope Key Takeaways
4.3 Revenue Growth Analysis, 2023 & 2029
4.4 Traditional PCR
4.4.1 Traditional PCR Market Estimates and Forecast, 2021-2029 (USD Million)
4.5 Real-time PCR
4.5.1 Real-time PCR Market Estimates and Forecast, 2021-2029 (USD Million)
4.6 Digital PCR
4.6.1 Digital PCR Market Estimates and Forecast, 2021-2029 (USD Million)
5 GLOBAL PCR & REAL-TIME PCR MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION
5.1 Introduction
5.2 PCR & Real-time PCR Molecular Diagnostics Market: Application Scope Key Takeaways
5.3 Revenue Growth Analysis, 2023 & 2029
5.4 Infectious Disease Testing
5.4.1 Infectious Disease Testing Market Estimates and Forecast, 2021-2029 (USD Million)
5.5 Oncology Testing
5.5.1 Oncology Testing Market Estimates and Forecast, 2021-2029 (USD Million)
5.6 Genetic Testing
5.6.1 Genetic Testing Market Estimates and Forecast, 2021-2029 (USD Million)
5.7 Others
5.7.1 Others Market Estimates and Forecast, 2021-2029 (USD Million)
6 GLOBAL PCR & REAL-TIME PCR MOLECULAR DIAGNOSTICS MARKET, BY END USER
6.1 Introduction
6.2 PCR & Real-time PCR Molecular Diagnostics Market: End User Scope Key Takeaways
6.3 Revenue Growth Analysis, 2023 & 2029
6.4 Hospitals
6.4.1 Hospitals Market Estimates and Forecast, 2021-2029 (USD Million)
6.5 Diagnostic Laboratories
6.5.1 Diagnostic Laboratories Market Estimates and Forecast, 2021-2029 (USD Million)
6.6 Academic & Research Centers
6.6.1 Academic & Research Centers Market Estimates and Forecast, 2021-2029 (USD Million)
6.7 Others
6.7.1 Others Market Estimates and Forecast, 2021-2029 (USD Million)
7 GLOBAL PCR & REAL-TIME PCR MOLECULAR DIAGNOSTICS MARKET, BY REGION
7.1 Introduction
7.2 North America PCR & Real-time PCR Molecular Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.2.1 By Technology
7.2.2 By Application
7.2.3 By End User
7.2.4 By Country
7.2.4.1 U.S. PCR & Real-time PCR Molecular Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.2.4.1.1 By Technology
7.2.4.1.2 By Application
7.2.4.1.3 By End User
7.2.4.2 Canada PCR & Real-time PCR Molecular Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.2.4.2.1 By Technology
7.2.4.2.2 By Application
7.2.4.2.3 By End User
7.2.4.3 Mexico PCR & Real-time PCR Molecular Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.2.4.3.1 By Technology
7.2.4.3.2 By Application
7.2.4.3.3 By End User
7.3 Europe PCR & Real-time PCR Molecular Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.3.1 By Technology
7.3.2 By Application
7.3.3 By End User
7.3.4 By Country
7.3.4.1 Germany PCR & Real-time PCR Molecular Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.3.4.1.1 By Technology
7.3.4.1.2 By Application
7.3.4.1.3 By End User
7.3.4.2 U.K. PCR & Real-time PCR Molecular Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.3.4.2.1 By Technology
7.3.4.2.2 By Application
7.3.4.2.3 By End User
7.3.4.3 France PCR & Real-time PCR Molecular Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.3.4.3.1 By Technology
7.3.4.3.2 By Application
7.3.4.3.3 By End User
7.3.4.4 Italy PCR & Real-time PCR Molecular Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.3.4.4.1 By Technology
7.3.4.4.2 By Application
7.2.4.4.3 By End User
7.3.4.5 Spain PCR & Real-time PCR Molecular Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.3.4.5.1 By Technology
7.3.4.5.2 By Application
7.2.4.5.3 By End User
7.3.4.6 Netherlands PCR & Real-time PCR Molecular Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.3.4.6.1 By Technology
7.3.4.6.2 By Application
7.2.4.6.3 By End User
7.3.4.7 Rest of Europe PCR & Real-time PCR Molecular Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.3.4.7.1 By Technology
7.3.4.7.2 By Application
7.2.4.7.3 By End User
7.4 Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.4.1 By Technology
7.4.2 By Application
7.4.3 By End User
7.4.4 By Country
7.4.4.1 China PCR & Real-time PCR Molecular Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.4.4.1.1 By Technology
7.4.4.1.2 By Application
7.4.4.1.3 By End User
7.4.4.2 Japan PCR & Real-time PCR Molecular Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.4.4.2.1 By Technology
7.4.4.2.2 By Application
7.4.4.2.3 By End User
7.4.4.3 India PCR & Real-time PCR Molecular Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.4.4.3.1 By Technology
7.4.4.3.2 By Application
7.4.4.3.3 By End User
7.4.4.4 South Korea PCR & Real-time PCR Molecular Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.4.4.4.1 By Technology
7.4.4.4.2 By Application
7.4.4.4.3 By End User
7.4.4.5 Singapore PCR & Real-time PCR Molecular Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.4.4.5.1 By Technology
7.4.4.5.2 By Application
7.4.4.5.3 By End User
7.4.4.6 Malaysia PCR & Real-time PCR Molecular Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.4.4.6.1 By Technology
7.4.4.6.2 By Application
7.4.4.6.3 By End User
7.4.4.7 Thailand PCR & Real-time PCR Molecular Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.4.4.7.1 By Technology
7.4.4.7.2 By Application
7.4.4.7.3 By End User
7.4.4.8 Indonesia PCR & Real-time PCR Molecular Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.4.4.8.1 By Technology
7.4.4.8.2 By Application
7.4.4.8.3 By End User
7.4.4.9 Vietnam PCR & Real-time PCR Molecular Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.4.4.9.1 By Technology
7.4.4.9.2 By Application
7.4.4.9.3 By End User
7.4.4.10 Taiwan PCR & Real-time PCR Molecular Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.4.4.10.1 By Technology
7.4.4.10.2 By Application
7.4.4.10.3 By End User
7.4.4.11 Rest of Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.4.4.11.1 By Technology
7.4.4.11.2 By Application
7.4.4.11.3 By End User
7.5 Middle East and Africa PCR & Real-time PCR Molecular Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.5.1 By Technology
7.5.2 By Application
7.5.3 By End User
7.5.4 By Country
7.5.4.1 Saudi Arabia PCR & Real-time PCR Molecular Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.5.4.1.1 By Technology
7.5.4.1.2 By Application
7.5.4.1.3 By End User
7.5.4.2 U.A.E. PCR & Real-time PCR Molecular Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.5.4.2.1 By Technology
7.5.4.2.2 By Application
7.5.4.2.3 By End User
7.5.4.3 Israel PCR & Real-time PCR Molecular Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.5.4.3.1 By Technology
7.5.4.3.2 By Application
7.5.4.3.3 By End User
7.5.4.4 South Africa PCR & Real-time PCR Molecular Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.5.4.4.1 By Technology
7.5.4.4.2 By Application
7.5.4.4.3 By End User
7.5.4.5 Rest of Middle East and Africa PCR & Real-time PCR Molecular Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.5.4.5.1 By Technology
7.5.4.5.2 By Application
7.5.4.5.2 By End User
7.6 Central and South America PCR & Real-time PCR Molecular Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.6.1 By Technology
7.6.2 By Application
7.6.3 By End User
7.6.4 By Country
7.6.4.1 Brazil PCR & Real-time PCR Molecular Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.6.4.1.1 By Technology
7.6.4.1.2 By Application
7.6.4.1.3 By End User
7.6.4.2 Argentina PCR & Real-time PCR Molecular Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.6.4.2.1 By Technology
7.6.4.2.2 By Application
7.6.4.2.3 By End User
7.6.4.3 Chile PCR & Real-time PCR Molecular Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.6.4.3.1 By Technology
7.6.4.3.2 By Application
7.6.4.3.3 By End User
7.6.4.4 Rest of Central and South America PCR & Real-time PCR Molecular Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.6.4.4.1 By Technology
7.6.4.4.2 By Application
7.6.4.4.3 By End User
8 COMPETITIVE LANDCAPE
8.1 Company Market Share Analysis
8.2 Four Quadrant Positioning Matrix
8.2.1 Market Leaders
8.2.2 Market Visionaries
8.2.3 Market Challengers
8.2.4 Niche Market Players
8.3 Vendor Landscape
8.3.1 North America
8.3.2 Europe
8.3.3 Asia Pacific
8.3.4 Rest of the World
8.4 Company Profiles
8.4.1 Abbott Laboratories
8.4.1.1 Business Description & Financial Analysis
8.4.1.2 SWOT Analysis
8.4.1.3 Products & Services Offered
8.4.1.4 Strategic Alliances between Business Partners
8.4.2 Bio-Rad Laboratories, Inc.
8.4.2.1 Business Description & Financial Analysis
8.4.2.2 SWOT Analysis
8.4.2.3 Products & Services Offered
8.4.2.4 Strategic Alliances between Business Partners
8.4.3 BioMérieux SA
8.4.3.1 Business Description & Financial Analysis
8.4.3.2 SWOT Analysis
8.4.3.3 Products & Services Offered
8.4.3.4 Strategic Alliances between Business Partners
8.4.4 Danaher Corporation
8.4.4.1 Business Description & Financial Analysis
8.4.4.2 SWOT Analysis
8.4.4.3 Products & Services Offered
8.4.4.4 Strategic Alliances between Business Partners
8.4.5 Thermo Fisher Scientific, Inc.
8.4.5.1 Business Description & Financial Analysis
8.4.5.2 SWOT Analysis
8.4.5.3 Products & Services Offered
8.4.5.4 Strategic Alliances between Business Partners
8.4.6 BECTON, DICKINSON AND COMPANY
8.4.6.1 Business Description & Financial Analysis
8.4.6.2 SWOT Analysis
8.4.6.3 Products & Services Offered
8.4.6.4 Strategic Alliances between Business Partners
8.4.7 F. Hoffmann-La Roche Ltd
8.4.7.1 Business Description & Financial Analysis
8.4.7.2 SWOT Analysis
8.4.7.3 Products & Services Offered
8.4.8.4 Strategic Alliances between Business Partners
8.4.8 QIAGEN N.V.
8.4.8.1 Business Description & Financial Analysis
8.4.8.2 SWOT Analysis
8.4.8.3 Products & Services Offered
8.4.8.4 Strategic Alliances between Business Partners
8.4.9 Hologic, Inc.
8.4.9.1 Business Description & Financial Analysis
8.4.9.2 SWOT Analysis
8.4.9.3 Products & Services Offered
8.4.9.4 Strategic Alliances between Business Partners
8.4.10 GRIFOLS
8.4.10.1 Business Description & Financial Analysis
8.4.10.2 SWOT Analysis
8.4.10.3 Products & Services Offered
8.4.10.4 Strategic Alliances between Business Partners
8.4.11 Other Companies
8.4.11.1 Business Description & Financial Analysis
8.4.11.2 SWOT Analysis
8.4.11.3 Products & Services Offered
8.4.11.4 Strategic Alliances between Business Partners
9 RESEARCH METHODOLOGY
9.1 Market Introduction
9.1.1 Market Definition
9.1.2 Market Scope & Segmentation
9.2 Information Procurement
9.2.1 Secondary Research
9.2.1.1 Purchased Databases
9.2.1.2 GMEs Internal Data Repository
9.2.1.3 Secondary Resources & Third Party Perspectives
9.2.1.4 Company Information Sources
9.2.2 Primary Research
9.2.2.1 Various Types of Respondents for Primary Interviews
9.2.2.2 Number of Interviews Conducted throughout the Research Process
9.2.2.3 Primary Stakeholders
9.2.2.4 Discussion Guide for Primary Participants
9.2.3 Expert Panels
9.2.3.1 Expert Panels Across 30+ Industry
9.2.4 Paid Local Experts
9.2.4.1 Paid Local Experts Across 30+ Industry Across each Region
9.3 Market Estimation
9.3.1 Top-Down Approach
9.3.1.1 Macro-Economic Indicators Considered
9.3.1.2 Micro-Economic Indicators Considered
9.3.2 Bottom Up Approach
9.3.2.1 Company Share Analysis Approach
9.3.2.2 Estimation of Potential Type Sales
9.4 Data Triangulation
9.4.1 Data Collection
9.4.2 Time Series, Cross Sectional & Panel Data Analysis
9.4.3 Cluster Analysis
9.5 Analysis and Output
9.5.1 Inhouse AI Based Real Time Analytics Tool
9.5.2 Output From Desk & Primary Research
9.6 Research Assumptions & Limitations
9.7.1 Research Assumptions
9.7.2 Research Limitations
LIST OF TABLES
1 Global PCR & Real-time PCR Molecular Diagnostics Market, By Technology, 2021-2029 (USD Mllion)
2 Traditional PCR Market, By Region, 2021-2029 (USD Mllion)
3 Real-time PCR Market, By Region, 2021-2029 (USD Mllion)
4 Digital PCR Market, By Region, 2021-2029 (USD Mllion)
5 Global PCR & Real-time PCR Molecular Diagnostics Market, By Application, 2021-2029 (USD Mllion)
6 Infectious Disease Testing Market, By Region, 2021-2029 (USD Mllion)
7 Oncology Testing Market, By Region, 2021-2029 (USD Mllion)
8 Genetic Testing Market, By Region, 2021-2029 (USD Mllion)
9 Others Market, By Region, 2021-2029 (USD Mllion)
10 Global PCR & Real-time PCR Molecular Diagnostics Market, By End User, 2021-2029 (USD Mllion)
11 Hospitals Market, By Region, 2021-2029 (USD Mllion)
12 Diagnostic Laboratories Market, By Region, 2021-2029 (USD Mllion)
13 Academic & Research Centers Market, By Region, 2021-2029 (USD Mllion)
14 Others Market, By Region, 2021-2029 (USD Mllion)
15 Regional Analysis, 2021-2029 (USD Mllion)
16 North America PCR & Real-time PCR Molecular Diagnostics Market, By Technology, 2021-2029 (USD Million)
17 North America PCR & Real-time PCR Molecular Diagnostics Market, By Application, 2021-2029 (USD Million)
18 North America PCR & Real-time PCR Molecular Diagnostics Market, By End User, 2021-2029 (USD Million)
19 North America PCR & Real-time PCR Molecular Diagnostics Market, By Country, 2021-2029 (USD Million)
20 U.S. PCR & Real-time PCR Molecular Diagnostics Market, By Technology, 2021-2029 (USD Million)
21 U.S. PCR & Real-time PCR Molecular Diagnostics Market, By Application, 2021-2029 (USD Million)
22 U.S. PCR & Real-time PCR Molecular Diagnostics Market, By End User, 2021-2029 (USD Million)
23 Canada PCR & Real-time PCR Molecular Diagnostics Market, By Technology, 2021-2029 (USD Million)
24 Canada PCR & Real-time PCR Molecular Diagnostics Market, By Application, 2021-2029 (USD Million)
25 Canada PCR & Real-time PCR Molecular Diagnostics Market, By End User, 2021-2029 (USD Million)
26 Mexico PCR & Real-time PCR Molecular Diagnostics Market, By Technology, 2021-2029 (USD Million)
27 Mexico PCR & Real-time PCR Molecular Diagnostics Market, By Application, 2021-2029 (USD Million)
28 Mexico PCR & Real-time PCR Molecular Diagnostics Market, By End User, 2021-2029 (USD Million)
29 Europe PCR & Real-time PCR Molecular Diagnostics Market, By Technology, 2021-2029 (USD Million)
30 Europe PCR & Real-time PCR Molecular Diagnostics Market, By Application, 2021-2029 (USD Million)
31 Europe PCR & Real-time PCR Molecular Diagnostics Market, By End User, 2021-2029 (USD Million)
32 Europe PCR & Real-time PCR Molecular Diagnostics Market, By Country 2021-2029 (USD Million)
33 Germany PCR & Real-time PCR Molecular Diagnostics Market, By Technology, 2021-2029 (USD Million)
34 Germany PCR & Real-time PCR Molecular Diagnostics Market, By Application, 2021-2029 (USD Million)
35 Germany PCR & Real-time PCR Molecular Diagnostics Market, By End User, 2021-2029 (USD Million)
36 U.K. PCR & Real-time PCR Molecular Diagnostics Market, By Technology, 2021-2029 (USD Million)
37 U.K. PCR & Real-time PCR Molecular Diagnostics Market, By Application, 2021-2029 (USD Million)
38 U.K. PCR & Real-time PCR Molecular Diagnostics Market, By End User, 2021-2029 (USD Million)
39 France PCR & Real-time PCR Molecular Diagnostics Market, By Technology, 2021-2029 (USD Million)
40 France PCR & Real-time PCR Molecular Diagnostics Market, By Application, 2021-2029 (USD Million)
41 France PCR & Real-time PCR Molecular Diagnostics Market, By End User, 2021-2029 (USD Million)
42 Italy PCR & Real-time PCR Molecular Diagnostics Market, By Technology, 2021-2029 (USD Million)
43 Italy PCR & Real-time PCR Molecular Diagnostics Market, By application, 2021-2029 (USD Million)
44 Italy PCR & Real-time PCR Molecular Diagnostics Market, By End User, 2021-2029 (USD Million)
45 Spain PCR & Real-time PCR Molecular Diagnostics Market, By Technology, 2021-2029 (USD Million)
46 Spain PCR & Real-time PCR Molecular Diagnostics Market, By Application, 2021-2029 (USD Million)
47 Spain PCR & Real-time PCR Molecular Diagnostics Market, By End User, 2021-2029 (USD Million)
48 Netherlands PCR & Real-time PCR Molecular Diagnostics Market, By Technology, 2021-2029 (USD Million)
49 Netherlands PCR & Real-time PCR Molecular Diagnostics Market, By Application, 2021-2029 (USD Million)
50 Netherlands PCR & Real-time PCR Molecular Diagnostics Market, By End User, 2021-2029 (USD Million)
51 Rest Of Europe PCR & Real-time PCR Molecular Diagnostics Market, By Technology, 2021-2029 (USD Million)
52 Rest Of Europe PCR & Real-time PCR Molecular Diagnostics Market, By Application, 2021-2029 (USD Million)
53 Rest of Europe PCR & Real-time PCR Molecular Diagnostics Market, By End User, 2021-2029 (USD Million)
54 Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market, By Technology, 2021-2029 (USD Million)
55 Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market, By Application, 2021-2029 (USD Million)
56 Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market, By End User, 2021-2029 (USD Million)
57 Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market, By Country, 2021-2029 (USD Million)
58 China PCR & Real-time PCR Molecular Diagnostics Market, By Technology, 2021-2029 (USD Million)
59 China PCR & Real-time PCR Molecular Diagnostics Market, By Application, 2021-2029 (USD Million)
60 China PCR & Real-time PCR Molecular Diagnostics Market, By End User, 2021-2029 (USD Million)
61 India PCR & Real-time PCR Molecular Diagnostics Market, By Technology, 2021-2029 (USD Million)
62 India PCR & Real-time PCR Molecular Diagnostics Market, By Application, 2021-2029 (USD Million)
63 India PCR & Real-time PCR Molecular Diagnostics Market, By End User, 2021-2029 (USD Million)
64 Japan PCR & Real-time PCR Molecular Diagnostics Market, By Technology, 2021-2029 (USD Million)
65 Japan PCR & Real-time PCR Molecular Diagnostics Market, By Application, 2021-2029 (USD Million)
66 Japan PCR & Real-time PCR Molecular Diagnostics Market, By End User, 2021-2029 (USD Million)
67 South Korea PCR & Real-time PCR Molecular Diagnostics Market, By Technology, 2021-2029 (USD Million)
68 South Korea PCR & Real-time PCR Molecular Diagnostics Market, By Application, 2021-2029 (USD Million)
69 South Korea PCR & Real-time PCR Molecular Diagnostics Market, By End User, 2021-2029 (USD Million)
70 malaysia PCR & Real-time PCR Molecular Diagnostics Market, By Technology, 2021-2029 (USD Million)
71 malaysia PCR & Real-time PCR Molecular Diagnostics Market, By Application, 2021-2029 (USD Million)
72 malaysia PCR & Real-time PCR Molecular Diagnostics Market, By End User, 2021-2029 (USD Million)
73 Thailand PCR & Real-time PCR Molecular Diagnostics Market, By Technology, 2021-2029 (USD Million)
74 Thailand PCR & Real-time PCR Molecular Diagnostics Market, By Application, 2021-2029 (USD Million)
75 Thailand PCR & Real-time PCR Molecular Diagnostics Market, By End User, 2021-2029 (USD Million)
76 Indonesia PCR & Real-time PCR Molecular Diagnostics Market, By Technology, 2021-2029 (USD Million)
77 Indonesia PCR & Real-time PCR Molecular Diagnostics Market, By Application, 2021-2029 (USD Million)
78 Indonesia PCR & Real-time PCR Molecular Diagnostics Market, By End User, 2021-2029 (USD Million)
79 Vietnam PCR & Real-time PCR Molecular Diagnostics Market, By Technology, 2021-2029 (USD Million)
80 Vietnam PCR & Real-time PCR Molecular Diagnostics Market, By Application, 2021-2029 (USD Million)
81 Vietnam PCR & Real-time PCR Molecular Diagnostics Market, By End User, 2021-2029 (USD Million)
82 Taiwan PCR & Real-time PCR Molecular Diagnostics Market, By Technology, 2021-2029 (USD Million)
83 Taiwan PCR & Real-time PCR Molecular Diagnostics Market, By Application, 2021-2029 (USD Million)
84 Taiwan PCR & Real-time PCR Molecular Diagnostics Market, By End User, 2021-2029 (USD Million)
85 Rest of Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market, By Technology, 2021-2029 (USD Million)
86 Rest of Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market, By Application, 2021-2029 (USD Million)
87 Rest of Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market, By End User, 2021-2029 (USD Million)
88 Middle East and Africa PCR & Real-time PCR Molecular Diagnostics Market, By Technology, 2021-2029 (USD Million)
89 Middle East and Africa PCR & Real-time PCR Molecular Diagnostics Market, By Application, 2021-2029 (USD Million)
90 Middle East and Africa PCR & Real-time PCR Molecular Diagnostics Market, By End User, 2021-2029 (USD Million)
91 Middle East and Africa PCR & Real-time PCR Molecular Diagnostics Market, By Country, 2021-2029 (USD Million)
92 Saudi Arabia PCR & Real-time PCR Molecular Diagnostics Market, By Technology, 2021-2029 (USD Million)
93 Saudi Arabia PCR & Real-time PCR Molecular Diagnostics Market, By Application, 2021-2029 (USD Million)
94 Saudi Arabia PCR & Real-time PCR Molecular Diagnostics Market, By End User, 2021-2029 (USD Million)
95 UAE PCR & Real-time PCR Molecular Diagnostics Market, By Technology, 2021-2029 (USD Million)
96 UAE PCR & Real-time PCR Molecular Diagnostics Market, By Application, 2021-2029 (USD Million)
97 UAE PCR & Real-time PCR Molecular Diagnostics Market, By End User, 2021-2029 (USD Million)
98 Israel PCR & Real-time PCR Molecular Diagnostics Market, By Technology, 2021-2029 (USD Million)
99 Israel PCR & Real-time PCR Molecular Diagnostics Market, By Application, 2021-2029 (USD Million)
100 Israel PCR & Real-time PCR Molecular Diagnostics Market, By End User, 2021-2029 (USD Million)
101 South Africa PCR & Real-time PCR Molecular Diagnostics Market, By Technology, 2021-2029 (USD Million)
102 South Africa PCR & Real-time PCR Molecular Diagnostics Market, By Application, 2021-2029 (USD Million)
103 South Africa PCR & Real-time PCR Molecular Diagnostics Market, By End User, 2021-2029 (USD Million)
104 Rest of Middle East and Africa PCR & Real-time PCR Molecular Diagnostics Market, By Technology, 2021-2029 (USD Million)
105 Rest of Middle East and Africa PCR & Real-time PCR Molecular Diagnostics Market, By Application, 2021-2029 (USD Million)
106 Rest of Middle East and Africa PCR & Real-time PCR Molecular Diagnostics Market, By End User, 2021-2029 (USD Million)
107 Central and South America PCR & Real-time PCR Molecular Diagnostics Market, By Technology, 2021-2029 (USD Million)
108 Central and South America PCR & Real-time PCR Molecular Diagnostics Market, By Application, 2021-2029 (USD Million)
109 Central and South America PCR & Real-time PCR Molecular Diagnostics Market, By End User, 2021-2029 (USD Million)
110 Central and South America PCR & Real-time PCR Molecular Diagnostics Market, By Country, 2021-2029 (USD Million)
111 Brazil PCR & Real-time PCR Molecular Diagnostics Market, By Technology, 2021-2029 (USD Million)
112 Brazil PCR & Real-time PCR Molecular Diagnostics Market, By Application, 2021-2029 (USD Million)
113 Brazil PCR & Real-time PCR Molecular Diagnostics Market, By End User, 2021-2029 (USD Million)
114 Argentina PCR & Real-time PCR Molecular Diagnostics Market, By Technology, 2021-2029 (USD Million)
115 Argentina PCR & Real-time PCR Molecular Diagnostics Market, By Application, 2021-2029 (USD Million)
116 Argentina PCR & Real-time PCR Molecular Diagnostics Market, By End User, 2021-2029 (USD Million)
117 Chile PCR & Real-time PCR Molecular Diagnostics Market, By Technology, 2021-2029 (USD Million)
118 Chile PCR & Real-time PCR Molecular Diagnostics Market, By Application, 2021-2029 (USD Million)
119 Chile PCR & Real-time PCR Molecular Diagnostics Market, By End User, 2021-2029 (USD Million)
120 Rest of Central and South America PCR & Real-time PCR Molecular Diagnostics Market, By Technology, 2021-2029 (USD Million)
121 Rest of Central and South America PCR & Real-time PCR Molecular Diagnostics Market, By Application, 2021-2029 (USD Million)
122 Rest of Central and South America PCR & Real-time PCR Molecular Diagnostics Market, By End User, 2021-2029 (USD Million)
123 Abbott Laboratories: Products & Services Offering
124 Bio-Rad Laboratories, Inc.: Products & Services Offering
125 BioMérieux SA: Products & Services Offering
126 Danaher Corporation: Products & Services Offering
127 Thermo Fisher Scientific, Inc.: Products & Services Offering
128 BECTON, DICKINSON AND COMPANY: Products & Services Offering
129 F. Hoffmann-La Roche Ltd : Products & Services Offering
130 QIAGEN N.V.: Products & Services Offering
131 Hologic, Inc.: Products & Services Offering
132 GRIFOLS: Products & Services Offering
133 Other Companies: Products & Services Offering
LIST OF FIGURES
1 Global PCR & Real-time PCR Molecular Diagnostics Market Overview
2 Global PCR & Real-time PCR Molecular Diagnostics Market Value From 2021-2029 (USD Mllion)
3 Global PCR & Real-time PCR Molecular Diagnostics Market Share, By Technology (2023)
4 Global PCR & Real-time PCR Molecular Diagnostics Market Share, By Application (2023)
5 Global PCR & Real-time PCR Molecular Diagnostics Market Share, By End User (2023)
6 Global PCR & Real-time PCR Molecular Diagnostics Market, By Region (Asia Pacific Market)
7 Technological Trends In Global PCR & Real-time PCR Molecular Diagnostics Market
8 Four Quadrant Competitor Positioning Matrix
9 Impact Of Macro & Micro Indicators On The Market
10 Impact Of Key Drivers On The Global PCR & Real-time PCR Molecular Diagnostics Market
11 Impact Of Challenges On The Global PCR & Real-time PCR Molecular Diagnostics Market
12 Porter’s Five Forces Analysis
13 Global PCR & Real-time PCR Molecular Diagnostics Market: By Technology Scope Key Takeaways
14 Global PCR & Real-time PCR Molecular Diagnostics Market, By Technology Segment: Revenue Growth Analysis
15 Traditional PCR Market, By Region, 2021-2029 (USD Mllion)
16 Real-time PCR Market, By Region, 2021-2029 (USD Mllion)
17 Digital PCR Market, By Region, 2021-2029 (USD Mllion)
18 Global PCR & Real-time PCR Molecular Diagnostics Market: By Application Scope Key Takeaways
19 Global PCR & Real-time PCR Molecular Diagnostics Market, By Application Segment: Revenue Growth Analysis
20 Infectious Disease Testing Market, By Region, 2021-2029 (USD Mllion)
21 Oncology Testing Market, By Region, 2021-2029 (USD Mllion)
22 Genetic Testing Market, By Region, 2021-2029 (USD Mllion)
23 Others Market, By Region, 2021-2029 (USD Mllion)
24 Global PCR & Real-time PCR Molecular Diagnostics Market: By End User Scope Key Takeaways
25 Global PCR & Real-time PCR Molecular Diagnostics Market, By End User Segment: Revenue Growth Analysis
26 Hospitals Market, By Region, 2021-2029 (USD Mllion)
27 Diagnostic Laboratories Market, By Region, 2021-2029 (USD Mllion)
28 Academic & Research Centers Market, By Region, 2021-2029 (USD Mllion)
29 Others Market, By Region, 2021-2029 (USD Mllion)
30 Regional Segment: Revenue Growth Analysis
31 Global PCR & Real-time PCR Molecular Diagnostics Market: Regional Analysis
32 North America PCR & Real-time PCR Molecular Diagnostics Market Overview
33 North America PCR & Real-time PCR Molecular Diagnostics Market, By Technology
34 North America PCR & Real-time PCR Molecular Diagnostics Market, By Application
35 North America PCR & Real-time PCR Molecular Diagnostics Market, By End User
36 North America PCR & Real-time PCR Molecular Diagnostics Market, By Country
37 U.S. PCR & Real-time PCR Molecular Diagnostics Market, By Technology
38 U.S. PCR & Real-time PCR Molecular Diagnostics Market, By Application
39 U.S. PCR & Real-time PCR Molecular Diagnostics Market, By End User
40 Canada PCR & Real-time PCR Molecular Diagnostics Market, By Technology
41 Canada PCR & Real-time PCR Molecular Diagnostics Market, By Application
42 Canada PCR & Real-time PCR Molecular Diagnostics Market, By End User
43 Mexico PCR & Real-time PCR Molecular Diagnostics Market, By Technology
44 Mexico PCR & Real-time PCR Molecular Diagnostics Market, By Application
45 Mexico PCR & Real-time PCR Molecular Diagnostics Market, By End User
46 Four Quadrant Positioning Matrix
47 Company Market Share Analysis
48 Abbott Laboratories: Company Snapshot
49 Abbott Laboratories: SWOT Analysis
50 Abbott Laboratories: Geographic Presence
51 Bio-Rad Laboratories, Inc.: Company Snapshot
52 Bio-Rad Laboratories, Inc.: SWOT Analysis
53 Bio-Rad Laboratories, Inc.: Geographic Presence
54 BioMérieux SA: Company Snapshot
55 BioMérieux SA: SWOT Analysis
56 BioMérieux SA: Geographic Presence
57 Danaher Corporation: Company Snapshot
58 Danaher Corporation: Swot Analysis
59 Danaher Corporation: Geographic Presence
60 Thermo Fisher Scientific, Inc.: Company Snapshot
61 Thermo Fisher Scientific, Inc.: SWOT Analysis
62 Thermo Fisher Scientific, Inc.: Geographic Presence
63 BECTON, DICKINSON AND COMPANY: Company Snapshot
64 BECTON, DICKINSON AND COMPANY: SWOT Analysis
65 BECTON, DICKINSON AND COMPANY: Geographic Presence
66 F. Hoffmann-La Roche Ltd : Company Snapshot
67 F. Hoffmann-La Roche Ltd : SWOT Analysis
68 F. Hoffmann-La Roche Ltd : Geographic Presence
69 QIAGEN N.V.: Company Snapshot
70 QIAGEN N.V.: SWOT Analysis
71 QIAGEN N.V.: Geographic Presence
72 Hologic, Inc.: Company Snapshot
73 Hologic, Inc.: SWOT Analysis
74 Hologic, Inc.: Geographic Presence
75 GRIFOLS: Company Snapshot
76 GRIFOLS: SWOT Analysis
77 GRIFOLS: Geographic Presence
78 Other Companies: Company Snapshot
79 Other Companies: SWOT Analysis
80 Other Companies: Geographic Presence
The Global PCR & Real-time PCR Molecular Diagnostics Market has been studied from the year 2019 till 2029. However, the CAGR provided in the report is from the year 2024 to 2029. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the PCR & Real-time PCR Molecular Diagnostics Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Frequently Asked Questions
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
Or view our licence options:
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
